Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

Participating Companies

Companies participating at ChinaBio® Partnering Forum 2020 to date.

France

3Biotech

Spain

3DforScience - Visuals for Bio & Health

China

3E Bioventures Capital

China

3SBio

United Kingdom

4D pharma plc

China

6 Dimensions Capital

 
United States

60 Degrees Pharmaceuticals LLC

United States

Aagami, Inc.

China

Abbott China

United States

Abfero Pharmaceuticals Inc.

Italy

Abiogen Pharma S.p.A.

United States

Abvivo

United Kingdom

Acacia Pharma

Belgium

Academiclabs

 
United States

Accelerated Biosciences

Taiwan

ACT GENOMICS

United States

AcuityBio Corporation

China

Adlai Nortye

China

AffaMed Therapeutic

Japan

AGC Biologics

Japan

AGC Inc.

 
United States

Agilent Technologies

 
Australia

Agilex Biolabs

Netherlands

AIPEX B.V.

Japan

Ajinomoto, Co., Inc

 
China

Akeso, Inc.

United States

Aleon Pharma International, Inc.

United States

Alloy Therapeutics

Singapore

Almac Pharmaceutical Services Pte. Ltd.

Canada

Alpha Cancer Technologies

Sweden

AlzeCure Pharma AB

China

AmCham Shanghai

China

Amgen

South Korea

AMTIXBIO CO., LTD.

Japan

AnGes, Inc.

United States

Angex Pharmaceutical Inc

 
China

AnHeart Therapeutics (Hangzhou) Co., Ltd.

 
United States

Anima Biotech

China

Annpo Biotechnology, Inc.

France

ANTABIO SAS

United States

Apexigen, Inc.

Japan

API Co.,Ltd.

Israel

Aposense

South Korea

AprilBio

United States

AQS, Ltd.

Netherlands

Aquilo BV

Switzerland

Araris Biotech AG

Gabon

Arbor Pharmaceuticals

United Kingdom

Arctoris Ltd

Netherlands

Ardena Bioanalysis BV

United Kingdom

Arecor Limited

United States

Arog Pharmaceuticals, Inc.

Japan

Asahi Kasei Pharma Corporation

Japan

Asajes Ventures

United States

Ascendia Pharmaceuticals LLC

Japan

Ascent Development Services

 
China

Ascentage Pharma Group

Germany

ASGENTO

 
United States

Asia Horizon

Singapore

AsiaBioNext Pte Ltd

 
China

Asieris Pharmaceuticals

Japan

ASKA Pharmaceutical Co.,Ltd.

United Kingdom

Aspire Pharma

Japan

Astellas Pharma Inc.

China

AstraZeneca

 
China

ATLATL Innovation Center

Germany

Atriva Therapeutics GmbH

United States

Aurinia Pharmaceuticals

Germany

BAG Health Care GmbH

United Kingdom

Barrington James

Switzerland

Basel Area Business & Innovation

Switzerland

Basilea Pharmaceutica International

 
Singapore

Bayer Healthcare

South Korea

BD Partners Asia, Inc.

China

BeiGene

China

Beijing Daxiang Biotech Co., Ltd

China

Beijing Optical Valley Innovation Real Estate Co., Ltd.

China

Beike Biotechnology Co., Ltd.

Switzerland

Bellevue Asset Management AG

Germany

Berlin Partner fr Wirtschaft und Technologie GmbH

Switzerland

BERNINA BioInvest Ltd

China

Betta Pharmaceuticals Co.,Ltd

South Korea

BeyondBio Inc

United States

BeyondSpring, Inc.

China

BFC GROUP

 
China

Bio2 Innovation Center

United States

BioCentury Inc

Germany

Biocon Ltd

China

BIOCYOTGEN

United States

Bioelectronica

United States

BioFactura, Inc.

China

BioFront

China

Biogen

China

BioInno Bioscience Co., Ltd.

Spain

Biokit Research & Development S.L.U.

 
South Korea

BIOLEADERS CORPORATION

Israel

BioLIneRx Ltd.

Germany

BioM Biotech Cluster Development GmbH

Lithuania

Biomapas

China

Bioon

United Kingdom

BioPartner UK

Spain

BioPharma Synergies, S.L.

 
France

Biophytis

China

Biosion, Inc

China

Biotech Pharmaceutical Co., Ltd

United States

Bio-TEchne

United States

Bio-Thera Solutions, Ltd

China

Biotheus

Switzerland

Bioversys AG

China

Bioworkshops

United States

BioWorld

Brazil

Biozeus Pharmaceuticals

United States

BL&H USA

China

Boehringer Ingelheim

Canada

Bold Therapeutics Inc.

 
United States

Boston Pharmaceuticals

United Kingdom

Bould Opportunities PLC

Japan

Brain Innovation Co., Inc

Japan

Braizon Therapeutics, Inc.

United States

BridgeBio Pharma

United States

Bridgewest Group

Japan

BrightPath Biotherapeutics Co.,Ltd.

China

British Consulate General Chongqing

United States

BVCF

Spain

CancerAppy

United States

Capital Family Office

China

CASI Pharmaceuticals?China?Co.,Ltd.

Lithuania

CasZyme

United Kingdom

Catalyst Advisors

Germany

Catenion GmbH

China

CBIG

Sweden

Cellevate

Japan

CellFree Sciences Co., Ltd.

United States

Cello Health BioConsulting

United States

Cend Therapeutics Inc.

 
Singapore

Cerecin

South Korea

CHA Vaccine Institute

United States

Charles River

 
Switzerland

CheckOrphan

Germany

ChemCon

China

CHIA TAI PHARMACEUTICAL INVESTMENT (BEIJING) CO. ,LTD

China

CHIA TAI TIANQING PHARMACEUTICAL (CTTQ)

China

Chime Biologics Limited

China

CHINA OTSUKA

China

China Resources Double-Crane Pharmaceutical Co., Ltd.

China

China Resources Pharmaceutical Group

China

ChinaBio Group

United States

Chinese American BioPharma Society

China

Chipscreen Biosciences

United Kingdom

Choice TeleMed

United States

Ciscovery Bio Inc

Singapore

Clinical Research Ventures Pte. Ltd.

Australia

CMAX Clinical Research Pty Ltd

France

Cofes France & China

Singapore

Collaborative Drug Discovery

Australia

Complete Phase Consulting

United Kingdom

congenica

United States

Constellation Pharmaceuticals

China

Cooley LLP

Denmark

Copenhagen Capacity

Australia

CoSec

Singapore

COVATE PHARMA PTE LTD

China

CPhI ????

China

CR Sanjiu Medical & Pharmaceutical

Japan

Craif Inc.

Singapore

Credevo Pte. Ltd.

United Kingdom

Crescendo Biologics Ltd.

Canada

Crescita Therapeutics Inc.

Netherlands

Cristal Therapeutics

Germany

CrystalsFirst GmbH

China

CSPC

United States

Cullgen Inc.

United States

CureMeta

China

Curon Biopharma

Hungary

Cyclolab Ltd

United States

Cytovia Therapeutics

France

Da Volterra

China

Decheng Capital

United States

Demy-Colton

Russian Federation

Dentons

France

DOMAIN THERAPEUTICS

United Kingdom

Domainex Ltd

South Korea

Dong-A ST

Japan

DOT World Co., Ltd.

Singapore

DotBio Pte. Ltd.

China

Drees & Sommer Shanghai

Lithuania

Droplet Genomics

China

DrugTimes

China

Duality Biologics

Japan

DyDo Pharma

 
United Kingdom

Dynastybio

Japan

EA Pharma Co., Ltd.

United States

EBD Group

Hong Kong

ECM Medical

China

Eddingpharm

United States

Eighty Eight Pharma, Inc.

China

Eisai (China) Pharmaceutical Co., Ltd.

Japan

Eisai Co., Ltd.

United States

Eli LIlly and Company

 
Japan

Elix, Inc.

United States

Elpis Biopharmaceuticals

 
China

Elpiscience

Taiwan

Energenesis Biomedical

Lithuania

Enterprise Lithuania

 
Argentina

Eolo Pharma S.A.

United States

EpicentRx

Japan

Epigeneron, Inc

 
China

EpimAb

Germany

EpiQMAx

Japan

Epistra Inc.

Japan

e-Projection K.K.

Netherlands

Erasmus MC

Belgium

Etherna Immunotherapies

Japan

Euro Japan Marketing Limited

France

EUROFINS ADME BIOANALYSES

Hong Kong

Evelo

United States

Evergreen Therapeutics, Inc.

Finland

Experimentica Ltd

United Kingdom

Exscientia

Portugal

FairJourney Biologics

Singapore

Ferring Pharmaceuticals

 
United States

Filtricine

China

Flanders Investment & Trade

United States

Fortress Biotech

United Kingdom

Freeline Therapeutics Limited

United Kingdom

F-star

South Korea

G2GBIO, Inc.

China

Gan&Lee Pharmaceutical Company

South Korea

GC Pharma

Japan

Gemseki

China

Geneception Inc.

Italy

Genenta Science

China

Generon

 
China

Genetron Health

China

Genor Bio

China

GenScript Biotech Corporation

Singapore

GERO

Japan

GEXVal Inc.

South Korea

Glaceum Inc.

United Kingdom

Glialign Limited

Canada

GlobalConnectworks Ltd.

China

GlobalData

Japan

GlycoTechnica Ltd.

Japan

GlyTech, Inc.

Japan

GN Corporation Co Ltd

Taiwan

Golden Biotechnology Corp.

South Korea

Green Cross Cell Corporation

Australia

GreenLight Clinical

China

Guangdong MJJ Biotechnologies Co. Ltd

United States

Gurus BioPharm Inc.

Japan

Hamamatsu Pharma Research, Inc.

China

Hangzhou M-D Technologies, Inc.

China

Hankang Capital

China

Hansoh Pharma

China

Harbour BioMed

Hong Kong

Health Advances

United States

Heat Biologics

China

HitGen

South Korea

HLB LifeScience

China

Huacells.com

South Korea

Huons

China

HUYA Bioscience International

Hungary

HYD LLC. for Cancer Research and Drug Development

United Kingdom

IAG / Bio Capital Impact Fund

Germany

IASON consulting

Japan

iBody Inc.

United Kingdom

IDACO Consulting Limited

 
South Korea

Idience

Japan

iHeart Japan Corporation

South Korea

ILSUNG Pharmaceuticals

China

I-Mab Biopharma Co., Ltd

Belgium

Imcyse

 
United States

ImmTide

 
China

Immunecent Biotechnology

United States

Immune-Onc Therapeutics

South Korea

Immunoforge

Belgium

ImmunXperts SA, a Nexelis Group Company

Germany

INCARE

Germany

Indivumed GmbH

Switzerland

Informa IPCo

China

InnoCare Pharma Limited

Netherlands

InnoCore Pharmaceuticals

China

Innovent Biologics

United Kingdom

IN-PART Publishing Ltd.

 
United States

Insmed

Switzerland

InSphero AG

India

Integral Biosciences

Switzerland

InterAx Biotech AG

United States

Intezyne Technologies Inc.

United Kingdom

Intract Pharma

Hong Kong

Intralinks

United States Minor Outlying Islands

InveniAI LLC

South Korea

Inventage Lab

France

Invest Eastern France

Lithuania

Invest Lithuania

Japan

iPS Academia Japan, Inc.

United States

Jade Brown and Associates

Poland

Jagiellonian University in Krakw

Japan

Japan External Trade Organization (JETRO)

China

Jefferies

China

JIANGSU AOSAIKANG PHARMACEUTICAL CO., LTD.

China

Jianmin Pharmaceutical Group Co., Ltd

United States

Johns Hopkins

 
China

Johnson & Johnson Innovation

China

JS InnoPharm (Shanghai) Ltd

Japan

JSR Corporation

Japan

JT Pharma

United States

Jubilant Therapeutics Inc

Singapore

JustPartnering

South Korea

JW Pharmaceutical

Japan

KAICO Ltd.

United States

Kairos

Japan

Kaken Pharmaceutical

China

Kanova Biopharmaceutical

United Kingdom

Karma Oncology

China

Kawin Technology

United Kingdom

KBI Biopharma, Inc.

China

KG Pharma

United States

Kind Pharmaceuticals

China

Kira

Japan

Kissei Pharmaceutical Co., Ltd

South Korea

KIST

Israel

Kitov Pharma LTD

Japan

KM Biologics Co., Ltd.

South Korea

Korea Prime Pharm. Co., LTD.

United States

Landmark Angels/Family Office

China

Lansen Pharmaceutical Holdings Limited

China

LAV

United States

Leading BioSciences Inc

South Korea

LegoChem Biosciences

Singapore

Leo Pharma Asia Pte. Ltd.

South Korea

LG Chem

United States

LianBio

Netherlands

Liberi Group

Japan

LiberoThera Co., Ltd

Sweden

LIDDS AB

United Kingdom

LifeArc

Italy

LifeSci Advisors

United Kingdom

LightOx Ltd

United Kingdom

Liminal BioSciences Inc.

China

Lingmed

China

Link health Group

Norway

LINK Medical Research

United States

LIPAC Oncology

Italy

Lo.Li Pharma International

China

Longly Capital

 
Switzerland

Lonza

Germany

LTS Lohmann Therapie-Systeme AG

Taiwan

Lumosa Therapeutics Co., Ltd

 
China

Luoxin Pharma

China

Lychee Group

Japan

M Bio Technology Inc.

Japan

MabGenesis Inc.

China

Mabwell Bioscience

United Kingdom

Macrophage Pharma Limited

United States

MaveriX Oncology

 
South Korea

MD Healthcare Inc.

Canada

MedBiome

United Kingdom

Medicxi

Japan

MediGear International Corporation

Japan

medilabo RFP, Inc.

South Korea

MedPacto, Inc

Japan

MedRx Co., Ltd.

China

MENARINI

 
Singapore

Merck

United Kingdom

Mereo BioPharma Group plc

United Kingdom

MGB Biopharma

Japan

MiCAN Technologies Inc.

Hong Kong

MicuRx Pharmaceuticals

Japan

miibio, Inc.

United States

MilliporeSigma

United States

Mirum Pharmaceuticals, Inc.

Japan

Mitsubishi Tanabe Pharma Corporation

Japan

Mitsui & Co. Global Investment, Inc.

Singapore

Moleac

Japan

Momotaro-Gene Inc.

China

Morningside

China

Morrison & Foerster

 
Japan

MSD

United States

MSQ Ventures

South Korea

Myriad Life Sciences

China

Nan Fung Life Sciences

China

Nanjing Anji BioTechnology Co., Ltd.

United States

Nano Clinical Ltd.

 
United Kingdom

NanoMab Technology Ltd

South Korea

National OncoVenture

Japan

NB Health Laboratory Co.Ltd.

United Kingdom

NCprots

Switzerland

NDA Group

Singapore

Neogenomics

 
United States

NeoProgen

United States

New Directions Technology Consulting LLC

Philippines

New Marketlink Pharmaceutical Corp

 
South Korea

NEXMOS

Australia

Nexomics

Japan

NextGeM Inc.

China

Nhwa Pharmaceuticals

Japan

Nobelpharma Co., Ltd.

Belgium

Novadip

Switzerland

Novartis Pharma AG

 
United States

Novian Health

China

Novo Nordisk A/S

China

Novotech

South Korea

NS Investment

Italy

Ntc srl

Austria

NUCLEUS NETWORK

United States

Nuventra Pharma Sciences

United States

NuvOx Pharma

South Korea

OCI Company

Russian Federation

OCT Clinical CRO

Japan

Oligogen, Inc.

South Korea

Oncocross

France

Oncodesign

United States

OncoMyx Therapeutics, Inc.

Austria

OncoOne

South Korea

Onegene Biotechnology

France

Osivax

United States

Overland Phamaceuticals

United Kingdom

Owlstone Medical

United Kingdom

Oxford Biomedica (UK) Ltd

United Kingdom

Oxford Vacmedix

United States

OxStem

United States

Path BioAnalytics

 
China

Patheon by Thermo Fisher Scientific

Australia

Patrys

United States

PepLib

 
China

Pfizer

South Korea

pH Pharma Co., Ltd.

 
China

Phagelux

Austria

PhagoMed Biopharma GmbH

United States

PHARM BRIDGE USA, Inc.

United Kingdom

Pharma Intelligence - Informa

Taiwan

PharmaEngine Inc.

China

PharmaLegacy Laboratories (Shanghai) Co.,ltd

United Kingdom

Pharmalicensing

South Korea

PharmaResearch Products

United States

PhaseBio

Singapore

Pierre Fabre Medicament

China

Pivotal Bioventure Partners

United States

Pkinetix Latin America

France

Premier Research

Singapore

Prestige BioPharma Group

Japan

PRISM BIOLAB Co., Ltd.

Germany

Profil GmbH

Japan

Progenicytejapan Co.,Ltd.

United Kingdom

ProImmune Ltd.

Spain

PROTEOS BIOTECH, SL

United States

Pullan Consulting

China

Qilu Pharmaceutical Co., Ltd.

China

Qiming Venture Partners

United States

Quan Capital

 
Sweden

QuiaPEG Pharmaceuticals AB

United States

Radius Health

 
Japan

RaQualia Pharma Inc.

United States

RareMoon Consulting

Japan

Real World Data Co., Ltd.

Israel

RedHill Biopharma Ltd.

United States

Regulus Therapeutics

China

Reistone Biopharma

United States

Renexes LLC

Japan

Repertoire Genesis Inc.

Japan

REPROCELL

United Kingdom

Results Healthcare

United Kingdom

Retrogenix Limited

Germany

Richter-Helm BioLogics

Russian Federation

Rionis

United States

Riptide Bioscience, Inc.

 
China

Roche

China

Rongsheng Investment Company

 
United States

RubrYc Therapeutics, Inc.

United Kingdom

Saint George Street Capital

Saudi Arabia

SAJA Pharmaceuticals

South Korea

Samsung Biologics

Lithuania

Sanobiotec

 
China

Sanofi

Japan

Sanwa Kagaku Kenkyusho Co.,Ltd

United States

SarcomedUSA

United Kingdom

SBA Ltd

Japan

SBI Biotech Co., Ltd.

United Kingdom

Scendea Ltd

China

SciClone Pharmaceuticals

Australia

Scientia Clinical Research

Japan

SCOHIA PHARMA, Inc.

Japan

Selexis / JSR Life Sciences

Japan

SENJU PHARMACEUTICAL CO., LTD.

United Kingdom

Sentinel Oncology

China

Sequoia Capital

United States

Sermonix Pharmaceuticals

 
China

Servier

Japan

Setsuro Tech Inc.

Canada

Shadow Lake Group Inc

China

Shanghai Allist Pharmaceuticals Co., Ltd.

China

Shanghai De Novo Pharmatech Co., Ltd.

China

Shanghai Haiyan Pharmaceutical Co. LTD

China

Shanghai Jemincare Pharmaceutical Company Ltd.

China

Shanghai Joyin Enterprise Management Co., Ltd.

China

Shanghai Pharma Holding

China

Shanghai Zhangjiang Medical Device Development Co., Ltd.

 
South Korea

Shaperon

China

Shenzhen Beimei pharma

China

Shenzhen EverGauge Science and Technology Co., Ltd.

China

Shenzhen Foncoo Pharmaceutical Co.,Ltd

Japan

Shiga International Patent Office

United States

Shinyusha Publishing

 
China

Shuimu BioSciences

China

Sichuan Kelun-Biotech Biopharmaceutical CO., Ltd

China

Sichuan Primed Shines Biotech Co., Ltd.

Belgium

Sillar Clinical NV

China

Simcere Pharmaceutical Group

China

Sinomune Pharmaceutical Co., Ltd.

South Korea

SM-Sino Technology Investment Co.,Ltd

 
United States

Soligenix, Inc.

United States

Soluble Biotech Inc.

United Kingdom

Sosei Heptares

Japan

SOUSEIKAI Global Clinical Research Center

Australia

Southern Star Research

United States

Southlake Pharmaceuticals Inc

United Kingdom

Southwood Research

South Korea

SPARK Biopharma

China

Springer Nature

United States

SRI International

Israel

Star Tree Ventures Ltd.

Australia

Starpharma Holdings Ltd

 
United States

STAT News

United States

Stingray Therapeutics

United States

Suntec Medical, Inc.

China

Suzhou Industrial Park Biotech Development Co., Ltd

United States

SVB Leerink

United Kingdom

Swansea University

Netherlands

Synaffix BV

Taiwan

SynCore Biotechnology

Italy

Syneos Health

Belgium

SYNGULON

 
Japan

Sysmex Corporation

Japan

TAGCyx Biotechnologies Inc.

Taiwan

TAHO Pharmaceuticals Ltd.

Japan

Taiho Pharmaceutical Co.LTD.

United States

Taiho Ventures, LLC

Taiwan

Taiwan Bio Industry Organization

Japan

Takara Bio Inc.

Saudi Arabia

Tamer Group

China

Tasly Biopharmaceuticals Co., Ltd.

China

Tasly Pharmaceuticals Group Co. Limited.

China

t-capital

Japan

TECH MANAGE CORP.

Japan

Teijin Pharma Limited

Germany

Telexos GmbH

United States

Teon Therapeutics, Inc.

United States

TERAIMMUNE, INC.

China

The American Chamber of Commerce in Shanghai

Hong Kong

The Chinese University of Hong Kong

Singapore

The Coulter Partnership Pte. Ltd.

Spain

The Patients Resource

Hong Kong

The University of Hong Kong

Canada

TheraPten Biosciences Inc.

Japan

ThinkCyte, Inc.

China

Tianjin GreenPine

Australia

Tismor Health & Wellness

Netherlands

TNO

Switzerland

TNT Medical Corporation

Switzerland

Topadur Pharma AG

United Kingdom

Torbay Pharmaceuticals

United States

Torreya

China

TOT BIOPHARM Company Limited

United States

TRACON Pharmaceuticals, Inc.

China

Tradestar Pharmaceutical Holding Group

Germany

TRINITY Life Sciences

China

Tririver Capital

United States

Tris Pharma

 
China

Tsimaging

China

Tsinghua Univeristy

Japan

Tsubota Laboratory, Inc.

Taiwan

TTY Biopharm Company Limited

Taiwan

TWi Biotechnology, Inc.

 
China

Twist Bioscience

 
United States

TYME Technologies Inc.

Lithuania

UAB Aconitum

Japan

Ube Industries, Ltd.

 
China

UK DIT

Japan

United Immunity, Co., Ltd.

United Kingdom

Vaccitech

Taiwan

VelocityHealth Securities, Inc.

Sweden

Veltio Pharma AB

Japan

Veneno Technologies Co. Ltd.

Switzerland

Venture Valuation

United States

Verastem Oncology

 
Singapore

VETTER PHARMA INTERNATIONAL GMBH

China

VISEN Pharmaceuticals

China

Viva BioInnovator (Viva Biotech Holding)

South Korea

Voronoi

Germany

Winhealth Pharma Group

 
United States

Winning Difference

China

Worg Pharma

United States

WuXi AppTec

United States

WuXi Biologics

China

Wuxi Hanhai Huamei Technology Development Co., Ltd.

Germany

XL-protein GmbH

China

Xuanzhu Biopharmaceutical Ltd.

China

Yabao Pharmaceutical Group Co., Ltd

China

YAFO Capital

Singapore

Yifan Pharmaceuticals

China

YILING PHARMACEUTICAL, INC.

China

Yipinhong Pharma

 
China

Yiviva

China

Yuanda China Law Offices

South Korea

Yuhan Corporation

China

YUNION Healthcare Ventures

China

Zai Lab

China

Zambon Group

Germany

ZentriForce Pharma Research GmbH

China

ZhenFund

China

ZhenTec

United States

Zion Pharma Limited

China

ZJBPB